See also this year's filing and all EDGAR filings for this company.
PDF Report 0001109196_2018_Mabvax_Therapeutics_Holdings_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001109196, Mabvax Therapeutics Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,207,518 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,826,003 |
| 2 | PropertyPlantAndEquipmentNet | 578,206 |
| 3 | remainder_Assets | 178,597 |
| 4 | LiabilitiesCurrent | 5,806,266 |
| 5 | LiabilitiesNoncurrent | 1,853,618 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,526,340 |
| 9 | ResearchAndDevelopmentExpense | 7,544,122 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -950,217 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,790,324 |
| 1 | Liabilities | 7,659,884 |
| 2 | Expenses | 18,070,462 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,130,440 |
| 5 | NetIncome | -19,020,679 |
| 6 | ComprehensiveNetIncome | -19,020,679 |
| 7 | BaseVar | 17,735,444 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.01 |
| 9 | EconomicCapitalRatio | 1.02 |
Edgar->Model Mapping
Feature Distribution
Change over Time
